The Chemours CompanyCCNYSE
Loading
EBITDA Margin Over TimeContracting
Percentile Rank14
3Y CAGR-31.1%
5Y CAGR-18.0%
Studio
Year-over-Year Change

EBITDA as a percentage of revenue

3Y CAGR
-31.1%/yr
vs -6.9%/yr prior
5Y CAGR
-18.0%/yr
Recent deceleration
Acceleration
-24.3pp
Decelerating
Percentile
P14
Within normal range
vs 5Y Ago
0.4x
Contraction
Streak
1 yr
Consecutive declineContracting
PeriodValueYoY Change
20255.72%-52.2%
202411.97%+269.3%
20233.24%-81.5%
202217.49%-5.8%
202118.57%+20.3%
202015.44%+19.3%
201912.94%-44.3%
201823.24%+6.9%
201721.75%+64.3%
201613.24%-